BioMarin Pharmaceutical Inc (BMRN) stock
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3091% above fair value
$57.23+0.53 (+0.93%)
Close on Nov 13, 2026Market cap $11.08BP/E 150.6Yield –
BioMarin Pharmaceutical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
BioMarin Pharmaceutical's profit margin for the twelve months ending Jun 30, 2026 was 2.1%. For fiscal 2025 it was 10.8%, against 15.0% the year before. The highest annual figure on record is 54.7% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10.8% | −4.1 |
| FY2024 | Dec 31, 2024 | 15.0% | +8.0 |
| FY2023 | Dec 31, 2023 | 6.9% | +0.2 |
| FY2022 | Dec 31, 2022 | 6.8% | +10.2 |
| FY2021 | Dec 31, 2021 | -3.5% | −49.4 |
| FY2020 | Dec 31, 2020 | 45.9% | +47.3 |
| FY2019 | Dec 31, 2019 | -1.4% | +3.8 |
| FY2018 | Dec 31, 2018 | -5.2% | +3.7 |
| FY2017 | Dec 31, 2017 | -8.9% | +47.5 |
| FY2016 | Dec 31, 2016 | -56.4% | −37.1 |
| FY2015 | Dec 31, 2015 | -19.3% | −1.4 |
| FY2014 | Dec 31, 2014 | -17.9% | +14.3 |
| FY2013 | Dec 31, 2013 | -32.2% | −9.3 |
| FY2012 | Dec 31, 2012 | -22.8% | −10.6 |
| FY2011 | Dec 31, 2011 | -12.2% | −66.9 |
| FY2010 | Dec 31, 2010 | 54.7% | +54.9 |
| FY2009 | Dec 31, 2009 | -0.2% | −10.5 |
| FY2008 | Dec 31, 2008 | 10.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 4.5% | −24.6 |
| Q1 FY2026 | Mar 31, 2026 | 13.8% | −11.1 |
| Q4 FY2025 | Dec 31, 2025 | -5.3% | −22.0 |
| Q3 FY2025 | Sep 30, 2025 | -4.0% | −18.2 |
| Q2 FY2025 | Jun 30, 2025 | 29.1% | +14.1 |
| Q1 FY2025 | Mar 31, 2025 | 24.9% | +11.3 |
| Q4 FY2024 | Dec 31, 2024 | 16.7% | +13.6 |
| Q3 FY2024 | Sep 30, 2024 | 14.2% | +7.3 |
| Q2 FY2024 | Jun 30, 2024 | 15.1% | +5.6 |
| Q1 FY2024 | Mar 31, 2024 | 13.7% | +5.1 |
| Q4 FY2023 | Dec 31, 2023 | 3.2% | +3.2 |
| Q3 FY2023 | Sep 30, 2023 | 6.9% | +8.3 |
| Q2 FY2023 | Jun 30, 2023 | 9.4% | +4.2 |
| Q1 FY2023 | Mar 31, 2023 | 8.5% | −14.7 |
| Q4 FY2022 | Dec 31, 2022 | -0.0% | +12.8 |
| Q3 FY2022 | Sep 30, 2022 | -1.3% | +7.6 |
| Q2 FY2022 | Jun 30, 2022 | 5.2% | +2.6 |
| Q1 FY2022 | Mar 31, 2022 | 23.3% | +19.7 |
| Q4 FY2021 | Dec 31, 2021 | -12.9% | −16.6 |
| Q3 FY2021 | Sep 30, 2021 | -8.9% | −173.5 |
| Q2 FY2021 | Jun 30, 2021 | 2.6% | +9.4 |
| Q1 FY2021 | Mar 31, 2021 | 3.6% | −12.6 |
| Q4 FY2020 | Dec 31, 2020 | 3.8% | +0.5 |
| Q3 FY2020 | Sep 30, 2020 | 164.6% | +152.7 |
| Q2 FY2020 | Jun 30, 2020 | -6.8% | +2.9 |
| Q1 FY2020 | Mar 31, 2020 | 16.2% | +30.3 |
| Q4 FY2019 | Dec 31, 2019 | 3.3% | +4.3 |
| Q3 FY2019 | Sep 30, 2019 | 11.9% | +15.2 |
| Q2 FY2019 | Jun 30, 2019 | -9.7% | −5.2 |
| Q1 FY2019 | Mar 31, 2019 | -14.1% | −2.3 |
| Q4 FY2018 | Dec 31, 2018 | -1.0% | +13.3 |
| Q3 FY2018 | Sep 30, 2018 | -3.2% | +0.5 |
| Q2 FY2018 | Jun 30, 2018 | -4.5% | +7.1 |
| Q1 FY2018 | Mar 31, 2018 | -11.8% | −6.5 |
| Q4 FY2017 | Dec 31, 2017 | -14.3% | +15.9 |
| Q3 FY2017 | Sep 30, 2017 | -3.7% | +9.6 |
| Q2 FY2017 | Jun 30, 2017 | -11.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -5.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -30.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -13.4% | – |
See a number that looks wrong?